Wolfe Research maintained an Outperform rating on Salesforce, Inc. (NYSE:CRM) on January 15, with a price target of $350 unchanged. The firm participated in Salesforce's Agentforce World Tour in Boston.
The $350 target suggests an upside potential of approximately 50%. Wolfe Research noted positive momentum for the company's AI portfolio.
Agentforce is increasingly becoming more integrated throughout the company's user interface, the firm added. Instead of depending on separate chat interactions, the system now proactively offers agent-powered suggestions within current workflows.
According to the firm's analysis, early customer deployments of Agentforce mainly focus on internal use cases. These include meeting setup, CRM data entry, and enterprise search, as well as customer service chatbots and sales development functions.
Three days earlier, on January 12, Raimo Lenschow from Barclays lifted the price target on Salesforce to $338 from $330. Barclays kept an Overweight rating on the stock.
The $338 target is slightly above the consensus 1-year median price target of $335. It offers an upside potential of about 44%.
Salesforce is among the stocks with the best earnings growth for the next 5 years.